How could weight-loss drugs change how Americans eat?
18 Apr 2024
How could weight-loss drugs change how Americans eat?

Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are on the rise in the USA, and many people are interested in seeing how taking them could impact their health. But with drugs like these helping to curb hunger pangs and cut back on cravings, how could they impact food and drink brands?

Jack Bobo

Jack Bobo is the director of the University of Nottingham’s Food Systems Institute. Bobo was previously the director of Global Food and Water Policy at The Nature Conservancy and CEO of Futurity, a food foresight company. Recognized by Scientific American as one of the 100 most influential people in biotechnology, he has also been the chief communications officer and SVP for global policy at Intrexon Corporation and a senior advisor for food policy at the US Department of State.

Devon Gholam

Dr. Devon Gholam is the vice president of science and innovation at Step Change Innovations, a sales accelerator for science-backed, branded ingredients in the functional food and beverage, nutraceutical, companion animal, and cosmeceutical and personal care industries. Dr. Gholam's career has included product development, applications, sales, technical sales, and technical writing at companies like the Kellogg Company, Ganeden Biotech, Roquette America, and Prepared Foods magazine. She received her PhD in food science from Purdue University, specialising in food chemistry. She's particularly interested in ingredients for gut health and women's health.

Isabelle Aron

Isabelle Aron is a freelance journalist covering food and drink, lifestyle, travel, and culture. She was previously features editor at Time Out London. She has written for publications including The Guardian, Evening Standard, The Times, Vogue, ELLE, Women’s Health, VICE, the Independent, i newspaper, Cosmopolitan, Stylist, Refinery29, and Radio Times.